Lanetta Bronté-Hall, MD, MPH, MSPH

President and Chief Health Officer

Email: info@fscdr.org

Phone: 954-397-3251

Fax: 954-374-6320

Departments

Administration

Education

Joint MD/MPH – Medicine and Health Policy Administration  – University of North Carolina School of Medicine and Gillings School of General Public Health (1993)

Honors & Awards

  • 2019 Honored as a Trailblazer in Healthcare by the Broward Community & Family Health Centers
  • 2017 – Present Interim President, James Sistrunk Medical Society (a subsidiary society of the National Medical Association)
  • 2017 Featured in Legacy Magazine’s 2017 Miami’s Most Powerful and Influential Black Leaders
  • 2016 Hollywood Business Woman of the Year Nominee by the Greater Hollywood Chamber of Commerce
  • 2012 – Present Founder and President, Foundation for Sickle Cell Disease Research (FSCDR)
  • 2013 – 2016 Associate Medical Director, Optum Health Medicaid Sickle Cell Management Program, United Health Group
  • 2014 Expert Panel Member, Evidence-Based Management of Sickle Cell Disease, National Institutes of Health, National Heart, Lung, and Blood Institute
  • 2012 – 2014 Senior Medical Advisor, Centers for Disease Control and Prevention, Division of Blood Disorders and Birth Defects
  • 2001 – 2012 Founder and Director, Sickle Cell Services, Memorial Healthcare System, Hollywood, FL 
  • 1993 Joint MD/MPH: Medicine and Health Policy and Administration, University of North Carolina School of Medicine and Gillings School of Global Public Health

Lanetta Bronté-Hall, MD, MPH, MSPH is responsible for strategic planning, scientific, and administrative oversight of the Foundation for Sickle Cell Disease Research (FSCDR). She is a leading national and international researcher and population health scientist in the field of sickle cell disease, rare blood disorders, community-based participatory research, and chronic disease management. Dr. Bronté-Hall has extensive experience in developing programs that are closely aligned with the recruitment and retention of underserved and underrepresented populations for treatment of Sickle Cell Disease and Breast Cancer, research and clinical trials. She is currently President and CEO of the Foundation for Sickle Cell Disease Research (FSCDR), Chief Health Officer (CHO) of the Sickle Care and Research Network, FSCDR, LLC, an independent full- service outpatient medical treatment and clinical trials center that offers medical care and coordinated care for underserved populations. Dr. Bronté-Hall held a faculty appointment at the University of Miami, Miller School of Medicine as an Associate Professor in the Department of Public Health Sciences, Department of Health Services Research and Policy. 

Dr. Bronté-Hall received her Bachelor of Arts in Biology and Master of Science degree in Medical Parasitology and Laboratory Practice from the University of North Carolina (UNC), Chapel Hill, Gillings School of Global Public Health. She then received a joint Doctor of Medicine and Master of Public Health with a specialization in Health Policy and Administration (Health Policy and Management) from the UNC School of Medicine and Gillings School of Global Public Health. She completed an internship in Internal Medicine at Tulane University School of Medicine and residency in Psychiatry at the University of Miami, Miller School of Medicine. In addition, she completed a Health Research and Educational Trust/American Hospital Association Fellowship in Cultural Competence and Leadership. 

Dr. Bronté-Hall spearheaded a Sickle Cell Disease and Thalassemia Registry that currently has approximately 2,600 individuals with a hemoglobinopathy. Dr. Bronté-Hall has served in several leadership positions including the Chief Medical Officer of the Sickle Cell Disease Association of America, Senior Medical Advisor to the Centers for Disease Prevention and Control, a member of the National Institutes of Health, National Heart, Lung and Blood Advisory Council, and a member of the 2014 Expert Panel for the National Institutes of Health, National Heart, Lung and Blood Institute Management of Sickle Cell Disease Guidelines. Dr. Bronté-Hall works tirelessly to create an environment of trust, sustainability and relevance, which has significantly increased participation in research by all members of the community.